Business Wire Press Releases - EIN Presswire - Press Release Distribution Service

Published on January 10, 2025 - 13:17 GMT

Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene ...

RhyGaze, a biotechnology company based in Basel, Switzerland and Philadelphia, Pa., USA, today announced that it has secured a Series A financing of USD 86 million. The round was led by GV (Google Ventures), alongside Arch Venture Partners, F-Prime Capital …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Naveris Announces Expansion of the NavDx® Test in Anal Cancer Molecular Residual Disease Surveillance

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the expanded commercial availability of the NavDx test for Molecular Residual Disease (MRD) detection in anal squamous cell carcinoma (ASCC) patients. …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

VIPR Solutions dominates the Lloyd’s Market with three new insurer customers

VIPR Solutions (VIPR), a leading provider of Delegated Authority technology, has secured multi-year contracts with three of the most respected and influential insurance brands operating within the UK Lloyd’s Market. This press release features multimedia. …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Enveda Welcomes Jason Kim as Chief Financial Officer

Enveda, a biotechnology company using AI to translate life’s chemistry into new medicines, today announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim brings more than 20 years of biopharmaceutical corporate development and …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Venu Holding Corporation to Ring Opening Bell at New York Stock Exchange, Celebrating Bold Fan-Founded and Fan-Owned Mission

Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a leading premium hospitality and live entertainment company built by music fans for music fans, is proud to announce its participation in the iconic New York Stock …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Arrivo BioVentures Announces Positive Results from qEEG and BNA™ Study of SP-624 on Neural Brain Activity Related to Depression ...

Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624’s novel epigenetic mechanism of action on neurological pathways. The findings provide insights into the potential antidepressant and cognitive …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Kirby McInerney LLP Urges Investors in Kyverna Therapeutics, Inc. to Inquire About Their Rights in Class Action Lawsuit

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) ( …

Distribution channels: ...

Published on January 10, 2025 - 13:17 GMT

SIXT USA Announces New Car Rental Branch at Louis Armstrong New Orleans International Airport

SIXT USA, a subsidiary of Sixt SE – a global leader in premium mobility services – announces the opening of its newest U.S. location at Louis Armstrong New Orleans International Airport (MSY). The opening marks SIXT’s first branch in Louisiana and expands …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Kardigan Launches with Industry-Leading Team to Modernize Cardiovascular Drug Development with Late-Stage Portfolio of ...

Kardigan, a heart health company modernizing cardiovascular drug development, launched today with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases closer to the cures they deserve. “For decades, …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Addgene Expands Viral Vector Service with Packaged on Request

Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, today announced the expansion of its viral vector service with Packaged on Request. Customers can now select an AAV plasmid from …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

WisdomTree Reports Monthly Metrics for December 2024

WisdomTree, Inc. (NYSE: WT), a global financial innovator, today released monthly metrics for December 2024, including assets under management (AUM) and flow data by asset class. Monthly Commentary: Inflows in U.S. equity and cryptocurrency products, …

Distribution channels: ...

Published on January 10, 2025 - 13:17 GMT

Tanger Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Tanger® (NYSE: SKT), a leading owner and operator of outlet and open-air retail shopping destinations, announced today that its financial results for the quarter and year ended December 31, 2024 will be released on Wednesday, February 19, 2025 after the …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Aircraft Interiors Market Research Report 2024: $20+ Billion Trends, Forecast Analysis & Growth Opportunities 2023-2032 - ...

The "Aircraft Interiors Market Size, Share, Trend, Forecast Analysis & Growth Opportunity: 2024-2032" report has been added to ResearchAndMarkets.com's offering. The Aircraft Interiors Market was valued at US$ 13 Billion in 2023 and is …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. This innovative test is the …

Distribution channels:

Published on January 10, 2025 - 13:17 GMT

Rallybio Highlights 2024 Accomplishments and Anticipated Milestones for 2025

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today highlighted its 2024 accomplishments and announced its anticipated …

Distribution channels:

Published on January 10, 2025 - 13:01 GMT

IonQ CEO on Timeline to Quantum Value

The following is a statement from Peter Chapman, Chairman and CEO of IonQ (NYSE: IONQ): Today’s classical computing hardware is limited by computational capacity and power requirements in ways that will likely prohibit society from ever being able to solve …

Distribution channels:

Published on January 10, 2025 - 13:01 GMT

E2open Announces Fiscal 2025 Third Quarter Financial Results

E2open Parent Holdings, Inc. (NYSE: ETWO) (“e2open” or the “Company”), the connected supply chain SaaS platform with the largest multi-enterprise network, today announced financial results for its fiscal third quarter ended November 30, 2024. “During the …

Distribution channels:

Published on January 10, 2025 - 12:44 GMT

Lazard Hires Stephen Finkel as Managing Director and Global Head of Sports Advisory

Lazard, Inc. (NYSE: LAZ) today announced that Stephen Finkel joined the firm as a Managing Director and Global Head of Sports Advisory, based in New York. In addition, the firm also welcomed Manoel Carvalho as a Managing Director and Bryan Tannenbaum as a …

Distribution channels: ...

Published on January 10, 2025 - 12:44 GMT

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau ...

Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept (pove) in mainland China, …

Distribution channels: